Publications
Lilly Challenges US FDA Classification Of Obesity Drug Retatrutide, Citing Chevron Overturn
Quoted, Pink Sheet Citeline Regulatory
Publications
Updates
Top Questions Health Care Providers Should Consider in a Post-Chevron World – A Polsinelli Round Table Discussion
Publications
What Challenges Will FDA Face In A Post-Chevron World?
Quoted, American Conference Institute
Updates
Challenges to LDT Final Rule Continue as Rule Goes into Effect
Updates
The Chevron Doctrine: Part II—Congress’s Reaction to the Repeal and the Legislative Process
Updates
Provider Reimbursement Disputes Go Back to 1984 Following Supreme Court’s Regulatory Reset
Updates
The Chevron Doctrine: Part I
